Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Selectra Investments Sicav - J Lamarck Pharma B Cap Fonds LU1224032463

110.96 EUR
2.20 EUR
2.02 %
22.11.2024
NAV

Nettoinventarwert (NAV)

110.96 EUR 2.20 EUR 2.02 %
Vortag 108.76 EUR Datum 22.11.2024

Selectra Investments Sicav - J Lamarck Pharma B Cap Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Sui Staking ETP CH1360612159 317.30%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Cardano ETP CH1102728750 143.48%
21Shares Ripple XRP ETP CH0454664043 85.69%
21Shares Solana staking ETP CH1114873776 79.79%
21Shares Algorand ETP CH1146882316 71.39%
21Shares Injective Staking ETP CH1360612134 20.65%
21Shares Immutable ETP CH1360612142 8.65%
Name ISIN Performance
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Cardano ETP CH1102728750 99.15%
21Shares Ripple XRP ETP CH0454664043 98.39%
21Shares Aave ETP CH1135202120 66.30%
21Shares Solana staking ETP CH1114873776 55.00%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 349.79%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 163.84%
21Shares Binance BNB ETP CH0496454155 159.17%
21Shares Bitcoin Core ETP CH1199067674 157.83%
21Shares Staking Basket Index ETP CH1210548892 155.86%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’935.11%
21Shares Bitcoin Core ETP CH1199067674 499.78%
21Shares Bitcoin ETP CH0454664001 484.60%
21Shares Bitcoin Suisse ETP CH0496484640 381.08%
21Shares Bitwise Select 10 Large Cap Crypto Index ETP CH0475986318 367.58%

Fundamentaldaten

Valor
ISIN LU1224032463
Emittent TMF FUND MANAGEMENT
Aufgelegt in Luxembourg
Auflagedatum 17.07.2015
Kategorie Branchen: Gesundheitswesen
Währung EUR
Volumen 8’843’605.27
Depotbank Quintet Private Bank (Europe) S.A.
Geschäftsjahresende 31.12.
Berichtsstand 14.11.2024

Anlagepolitik

So investiert der Selectra Investments Sicav - J Lamarck Pharma B Cap Fonds: The main objective of this Sub-Fund is to profit from increasing share prices in the pharmaceutical sector worldwide. The focus is on mature top tier pharmaceutical companies and companies with interesting pipeline of products in development in a single or numerous markets. The followed investment policy will enable the Sub-Fund to increase overall return by active stock selection of companies, offering the most promising technology platform.

ETP Performance: Selectra Investments Sicav - J Lamarck Pharma B Cap Fonds

Performance 1 Jahr
3.14
Performance 2 Jahre
-3.96
Performance 3 Jahre
1.00
Performance 5 Jahre
23.45
Performance 10 Jahre -